WO2005049077A3 - Avian vaccine effective against infectious bursal disease virus - Google Patents

Avian vaccine effective against infectious bursal disease virus Download PDF

Info

Publication number
WO2005049077A3
WO2005049077A3 PCT/US2004/038468 US2004038468W WO2005049077A3 WO 2005049077 A3 WO2005049077 A3 WO 2005049077A3 US 2004038468 W US2004038468 W US 2004038468W WO 2005049077 A3 WO2005049077 A3 WO 2005049077A3
Authority
WO
WIPO (PCT)
Prior art keywords
disease virus
bursal disease
infectious bursal
effective against
against infectious
Prior art date
Application number
PCT/US2004/038468
Other languages
French (fr)
Other versions
WO2005049077A2 (en
Inventor
Jagdev M Sharma
Original Assignee
Univ Minnesota
Jagdev M Sharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota, Jagdev M Sharma filed Critical Univ Minnesota
Publication of WO2005049077A2 publication Critical patent/WO2005049077A2/en
Publication of WO2005049077A3 publication Critical patent/WO2005049077A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10061—Methods of inactivation or attenuation
    • C12N2720/10063—Methods of inactivation or attenuation by chemical treatment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10061—Methods of inactivation or attenuation
    • C12N2720/10064—Methods of inactivation or attenuation by serial passage

Abstract

A poultry vaccine is provided having a biological agent or microbial component that is effective in stimulating a protective cellular and humoral immune response to Infectious Bursal Disease Virus (IBDV). Methods are also provided for making the vaccine and for vaccinating poultry by administering such a vaccine.
PCT/US2004/038468 2003-11-17 2004-11-17 Avian vaccine effective against infectious bursal disease virus WO2005049077A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71482203A 2003-11-17 2003-11-17
US10/714,822 2003-11-17

Publications (2)

Publication Number Publication Date
WO2005049077A2 WO2005049077A2 (en) 2005-06-02
WO2005049077A3 true WO2005049077A3 (en) 2005-11-24

Family

ID=34619896

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/038468 WO2005049077A2 (en) 2003-11-17 2004-11-17 Avian vaccine effective against infectious bursal disease virus

Country Status (1)

Country Link
WO (1) WO2005049077A2 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824668A (en) * 1987-03-09 1989-04-25 Sterwin Laboratories Inc. Attenuated infectious bursal disease virus strain and vaccine therefrom
EP0352835A1 (en) * 1988-07-21 1990-01-31 Akzo Nobel N.V. IBDV production in continuous cell lines
US5064646A (en) * 1988-08-02 1991-11-12 The University Of Maryland Novel infectious bursal disease virus
EP0600723A2 (en) * 1992-12-01 1994-06-08 Abic Limited Infectious bursal disease vaccine
WO2002072139A1 (en) * 2001-03-09 2002-09-19 Regents Of The University Of Minnesota Avian vaccine effective against infectious bursal disease virus
WO2002096940A2 (en) * 2001-05-31 2002-12-05 Id-Lelystad, Institut Voor Dierhouderij En Diergezondheid B.V. Attenuated very virulent infectious bursal disease virus

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824668A (en) * 1987-03-09 1989-04-25 Sterwin Laboratories Inc. Attenuated infectious bursal disease virus strain and vaccine therefrom
EP0352835A1 (en) * 1988-07-21 1990-01-31 Akzo Nobel N.V. IBDV production in continuous cell lines
US5064646A (en) * 1988-08-02 1991-11-12 The University Of Maryland Novel infectious bursal disease virus
EP0600723A2 (en) * 1992-12-01 1994-06-08 Abic Limited Infectious bursal disease vaccine
WO2002072139A1 (en) * 2001-03-09 2002-09-19 Regents Of The University Of Minnesota Avian vaccine effective against infectious bursal disease virus
WO2002096940A2 (en) * 2001-05-31 2002-12-05 Id-Lelystad, Institut Voor Dierhouderij En Diergezondheid B.V. Attenuated very virulent infectious bursal disease virus

Also Published As

Publication number Publication date
WO2005049077A2 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
NO20015073D0 (en) vaccinations
HK1211864A1 (en) Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus
AU7814498A (en) Multivalent (in ovo) avian vaccine
WO2004080403A3 (en) Influenza virus vaccine
WO2007092792A3 (en) Yeast-based vaccine for inducing an immune response
WO2006068663A3 (en) Vaccine compositions for treating coronavirus infection
WO2006044923A3 (en) Yeast-based therapeutic for chronic hepatitis c infection
DE69939747D1 (en) METHOD OF DNA VACCINATION
ATA1302001A (en) METHOD FOR IDENTIFYING, ISOLATING AND PRODUCING ANTIGENS AGAINST A SPECIFIC PATHOGEN
WO2003059381A3 (en) Immunogenic preparations and vaccines on the basis of mrna
WO2007002470A3 (en) Inactivated chimeric vaccines and related methods of use
WO2002013855A3 (en) Vaccines containing ribavirin and methods of use thereof
WO2003059385A3 (en) Hiv vaccine and method of use
WO2004032860A3 (en) Hiv vaccine formulations
EA200702079A1 (en) VACCINE
MXPA03009763A (en) Foot and mouth disease virus vaccine.
EP2272949A3 (en) Infectious bursal disease virus antigenic isolates and vaccines
WO2003017755A3 (en) Mycoplasma bovis challenge model, methods for administering m.bovis and methods for inducing pneumonic lung lesions
AU2003243663A1 (en) Vaccines for suppressing ige-mediated allergic disease and methods for using the same
WO2005049077A3 (en) Avian vaccine effective against infectious bursal disease virus
WO2007047256A3 (en) Svv-based animal vaccines and uses thereof
WO2003032917A3 (en) Hookworm vaccine
NZ544453A (en) Vaccine composition for vaccinating dogs against canine infectious respiratory disease (cird)
WO2004100640A3 (en) Marek’s disease virus vaccine
AU5098700A (en) Dna vaccine for protecting an avian against infectious bursal disease virus

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase